Dr. Mark Christopher Genovese, MD is a Rheumatologist (Joints & Arthritis Specialist) - General practicing in Palo Alto, CA
He has not yet shared a personalized biography with Doctor.com.
| Publication | Publisher | Title | Published |
|---|---|---|---|
| Other Publication | RHEUMATOLOGY | Novel small molecule therapeutics in rheumatoid arthritis | 2013 |
| Other Publication | JOURL OF RHEUMATOLOGY | Longterm Safety and Efficacy of Tocilizumab in Patients with Rheumatoid Arthritis | 2013 |
| Other Publication | Anls of the rheumatic diseases | Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding | 2013 |
| Other Publication | JOURL OF RHEUMATOLOGY | Efficacy and Safety of Belimumab in Patients with Rheumatoid Arthritis: A Phase II, Randomized | 2013 |
| Other Publication | JOURL OF RHEUMATOLOGY | Effects of Fostamatinib (R788), an Oral Spleen Tyrosine Kise Inhibitor | 2013 |
| Other Publication | ARTHRITIS AND RHEUMATISM | Tabalumab in Rheumatoid Arthritis Patients With an Idequate Response to Methotrexate | 2013 |
| Other Publication | JOURL OF ORTHOPAEDIC RESEARCH | Effects of sclerostin antibody on healing of a non-critical size femoral bone defect | 2013 |
| Other Publication | JOURL OF RHEUMATOLOGY | Longterm Safety and Efficacy of Abatacept Through 5 Years of Treatment in Patients with Rheumatoid | 2012 |
| Other Publication | JOURL OF RHEUMATOLOGY | Effect of Golimumab on Patient-reported Outcomes in Rheumatoid Arthritis | 2012 |
| Other Publication | Anls of the rheumatic diseases | Tabalumab, an anti-BAFF monoclol antibody | |
| Other Publication | ARTHRITIS AND RHEUMATISM | Subcutaneous Abatacept Versus Intravenous Abatacept A Phase IIIb Noninferiority Study | 2011 |
| Other Publication | ARTHRITIS AND RHEUMATISM | Atacicept in Patients With Rheumatoid Arthritis | 2011 |
| Other Publication | JOURL OF RHEUMATOLOGY | A 24-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy of | 2011 |
| Other Publication | ARTHRITIS AND RHEUMATISM | An Oral Syk Kise Inhibitor in the Treatment of Rheumatoid Arthritis A Three-Month Randomized | 2011 |
| Other Publication | ARTHRITIS AND RHEUMATISM | LY2439821, a Humanized Anti-Interleukin-17 Monoclol Antibody | 2010 |
| Other Publication | ANLS OF THE RHEUMATIC DISEASES | Safety of biological therapies following rituximab treatment in rheumatoid arthritis patients | 2009 |
| Other Publication | JOURL OF RHEUMATOLOGY | First Report of Idiopathic Granulomatous Mastitis Treated with Methotrexate Monotherapy | 2009 |
| Other Publication | JOURL OF RHEUMATOLOGY | Less Radiographic Progression with Adalimumab Plus Methotrexate Versus Methotrexate Monotherapy | 2009 |
| Other Publication | JOURL OF BIOMEDICAL MATERIALS RESEARCH PART A | Efficacy of a p38 mitogen activated protein kise inhibitor | 2009 |
| Other Publication | ARTHRITIS AND RHEUMATISM | Inhibition of p38: Has the Fat Lady Sung | 2009 |
| Other Publication | ARTHRITIS RESEARCH & THERAPY | Blood autoantibody and cytokine profiles predict response to anti | 2009 |
| Other Publication | ARTHRITIS AND RHEUMATISM | Interleukin-6 Receptor Inhibition With Tocilizumab Reduces Disease Activity in Rheumatoid Arthritis | 2008 |
| Other Publication | ARTHRITIS AND RHEUMATISM | Ocrelizumab, a humanized anti-CD20 monoclol antibody | 2008 |
| Other Publication | ANLS OF THE RHEUMATIC DISEASES | Efficacy and safety of the selective co | 2008 |
| Other Publication | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | Efficacy results from pivotal clinical trials with abatacept | 2007 |
| Other Publication | ARCHIVES OF DERMATOLOGY | A pilot trial of rituximab in the treatment of patients with dermatomyositis | 2007 |
| Other Publication | ANLS OF THE RHEUMATIC DISEASES | Proteomic alysis of secreted proteins in early rheumatoid arthritis | 2007 |
| Other Publication | JOURL OF RHEUMATOLOGY | A pilot study of tumor necrosis factor inhibition in erosive | 2007 |
| Other Publication | JOURL OF RHEUMATOLOGY | Safety and efficacy of adalimumab in treatment of patients with psoriatic arthritis who had failed | 2007 |
| Other Publication | JOURL OF CLINICAL INVESTIGATION | Selective tyrosine kise inhibition by imatinib mesylate for the treatment of autoimmune arthritis | 2006 |
| Other Publication | JOURL OF RHEUMATOLOGY | A randomized, blinded | 2005 |
| Other Publication | Current rheumatology reports | Magement of co-morbidities and general medical conditions in patients with rheumatoid arthritis. | 2005 |
| Other Publication | NEW ENGLAND JOURL OF MEDICINE | Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition | 2005 |
| Other Publication | ARTHRITIS AND RHEUMATISM | Antigen microarray profiling of autoantibodies in rheumatoid arthritis | 2005 |
| Other Publication | JOURL OF RHEUMATOLOGY | Longterm safety, efficacy | 2005 |
| Other Publication | AMERICAN JOURL OF OBSTETRICS AND GYNECOLOGY | Factors that predict prematurity | 2005 |
| Other Publication | JCR-JOURL OF CLINICAL RHEUMATOLOGY | Biologic therapies in clinical development for the treatment of rheumatoid arthritis | 2005 |
| Other Publication | JOURL OF BIOMEDICAL MATERIALS RESEARCH PART A | Temporal effects of a COX-2-selective NSAID on bone ingrowth | 2005 |
| Other Publication | CLINICAL ORTHOPAEDICS AND RELATED RESEARCH | Pharmacologic modulation of periprosthetic osteolysis | 2005 |
| Other Publication | RHEUMATIC DISEASE CLINICS OF NORTH AMERICA | Associations between rheumatoid arthritis and maligncy | 2004 |
| Other Publication | ARTHRITIS AND RHEUMATISM | Combition therapy with etanercept | 2004 |
| Other Publication | RHEUMATIC DISEASE CLINICS OF NORTH AMERICA | Treatment of rheumatoid arthritis with etanercept | 2004 |
| Other Publication | ANLS OF THE RHEUMATIC DISEASES | Unlocking the PAD lock on rheumatoid arthritis | 2004 |
| Other Publication | Arthritis research & therapy | A randomized, controlled trial of interferon-beta | 2004 |
| Other Publication | JOURL OF RHEUMATOLOGY | Interleukin 1 receptor antagonist inhibits localized bone formation in vivo | 2003 |
| Other Publication | INTERTIOL JOURL OF IMMUNOPATHOLOGY AND PHARMACOLOGY | COX-2 selective inhibitors and bone | 2003 |
| Other Publication | JOURL OF MAGNETIC RESONCE IMAGING | Imaging of the articular cartilage in osteoarthritis of the knee joint | 2003 |
| Other Publication | JOURL OF BIOMEDICAL MATERIALS RESEARCH PART A | Modulation of bone ingrowth | 2003 |
| Other Publication | CURRENT OPINION IN RHEUMATOLOGY | Rheumatic syndromes associated with maligncy | 2003 |
| Other Publication | JOURL OF ORTHOPAEDIC RESEARCH | COX-2 selective NSAID decreases bone ingrowth in vivo | 2002 |
| Other Publication | jourl of materl-fetal & neotal medicine | Central nervous system lupus and pregncy: 11-year experience at a single center. | 2002 |
| Other Publication | ARTHRITIS AND RHEUMATISM | Etanercept versus methotrexate in patients with early rheumatoid arthritis - Two | 2002 |
| Other Publication | ARTHRITIS AND RHEUMATISM | Long-term followup of patients treated with total lymphoid irradiation for lupus nephritis | 2002 |
| Other Publication | TURE MEDICINE | Autoantigen microarrays for multiplex characterization of autoantibody responses | 2002 |
| Other Publication | AMERICAN JOURL OF PATHOLOGY | Expression of the chemokine receptors CCR4, CCR5 | 2002 |
| Other Publication | JOURL OF CLINICAL INVESTIGATION | Rules of chemokine receptor association with T cell polarization in vivo | 2001 |
| Other Publication | ARTHRITIS AND RHEUMATISM | Demyeliting and neurologic events reported in association with tumor necrosis factor alpha | 2001 |
| Other Publication | ARTHRITIS AND RHEUMATISM | Treatment of rheumatoid arthritis with total lymphoid irradiation - Long-term survival | 2001 |
| Other Publication | JOURL OF CLINICAL INVESTIGATION | Bonzo/CXCR6 expression defines type 1 | 2001 |
| Other Publication | HOSPITAL PRACTICE | Current magement of rheumatoid arthritis | 2001 |
| Other Publication | JOURL OF IMMUNOLOGY | Cutting edge: A novel chemokine ligand for CCR10 and CCR3 expressed by epithelial cells in mucosal | 2000 |
| Other Publication | JOURL OF EXPERIMENTAL MEDICINE | Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine | 2000 |
| Other Publication | POSTGRADUATE MEDICINE | Joint and soft-tissue injection - A useful adjuvant to systemic and local treatment | 1998 |
| Other Publication | WESTERN JOURL OF MEDICINE | Fever, rash, and arthritis in a woman with silicone gel breast implants | 1997 |
| Other Publication | SOUTHERN MEDICAL JOURL | Lemierre's syndrome | 1997 |
Dr. Mark Christopher Genovese, MD has not yet indicated the hospitals that he is affiliated with.
Years In Practice: 26 (started in 1999)
Accepts New Patients: Yes
Dr. Mark Christopher Genovese, MD has not yet listed the medications that he commonly prescribes.
Dr. Mark Christopher Genovese, MD has not yet added any information about his practice's billing policies and payment options.
